Whole Body Vibration Therapy in Participants With MS Related Balance Deficits

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dennis Enix, DC, MBA, Logan College of Chiropractic
ClinicalTrials.gov Identifier:
NCT00510523
First received: July 31, 2007
Last updated: May 2, 2013
Last verified: May 2013
  Purpose

The purpose of this investigation is to determine the effect of Whole Body Vibration Therapy (WBV) on balance in participants with multiple sclerosis (MS) related balance deficits as measured by the NeuroCom Balance Master, the Sapphire IIME EMG Device and the Kurtzke Expanded Disability Status Scale (EDSS) and the Berg Balance Score.


Condition Intervention
Multiple Sclerosis
Device: Whole Body Vibration machine

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Whole Body Vibration Therapy in Participants With MS Related Balance Deficits

Resource links provided by NLM:


Further study details as provided by Logan College of Chiropractic:

Primary Outcome Measures:
  • NeuroCom Balance Master
  • SF-EMG Nerve conduction velocity test
  • Berg balance score

Estimated Enrollment: 80
Study Start Date: October 2006
Estimated Study Completion Date: November 2007
  Eligibility

Ages Eligible for Study:   25 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Logan student, staff, or faculty or general public with a minimal of 2 year history of diagnosed Multiple Sclerosis (MS)

Exclusion Criteria:

  • Visual or vestibular condition that would affect balance
  • Non-Ms related systemic illness that would have an adverse effect on balance
  • Local infection, acute inflammation, injury, tumors or other malignancy, recent wounds, diabetes
  • Any unstable joints of the lower extremity, recent hip and knee joints or fitted hip or knee pins, bolts and/or plates
  • Acute thrombosis
  • Severe migraine, epilepsy
  • Serious cardiovascular disease, wearing a pacemaker
  • Any Spinal manipulation within 48 hours
  • Acute disc herniation, discopathy or spondylolysis
  • Prescription or herbal muscle stimulants, relaxants, etc. that could affect balance
  • Any implanted device or prosthesis or intrauterine IUD type of device
  • Pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00510523

Locations
United States, Missouri
Logan University, College of Chirpractic
Chesterfield, Missouri, United States, 63017
Logan University, College of Chiropractic
Chesterfield, Missouri, United States, 63017
Sponsors and Collaborators
Logan College of Chiropractic
Investigators
Principal Investigator: Dennis Enix, DC, MBA Logan College of Chiropractic
Principal Investigator: Dennis Enix, DC, MBA Logan University
  More Information

Publications:
Responsible Party: Dennis Enix, DC, MBA, Assistant Professor, Logan College of Chiropractic
ClinicalTrials.gov Identifier: NCT00510523     History of Changes
Other Study ID Numbers: RD0731060030
Study First Received: July 31, 2007
Last Updated: May 2, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Logan College of Chiropractic:
MS
Balance
Multiple Sclerosis

Additional relevant MeSH terms:
Multiple Sclerosis
Sclerosis
Demyelinating Autoimmune Diseases, CNS
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Demyelinating Diseases
Autoimmune Diseases
Immune System Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on July 24, 2014